BioBridgeXAll companies

Valanbio Therapeutics, Inc.

Pharmaceutical company · Raleigh, North Carolina, United States

Valanbio Therapeutics, Inc. is a pharmaceutical company headquartered in Raleigh, North Carolina, United States. Its earliest recorded incorporation is in 2015. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $1.6 million in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $421,000 sold in a notice filed in 2020.

Profile compiled from public records. Is this your company? Request a correction or update

Valanbio Therapeutics at a glance

Typepharmaceutical company
HeadquartersRaleigh, North Carolina, United States
Earliest incorporation on record2015
Employees (self-reported, 2020)1
SEC CIK1771623

What does Valanbio Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $1.6 million in total (2020). NIH funding came from the National Institute of Allergy and Infectious Diseases.

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $421,000 sold (2020).

Frequently asked questions about Valanbio Therapeutics

Where is Valanbio Therapeutics headquartered?

Valanbio Therapeutics, Inc. is headquartered in Raleigh, North Carolina, United States.

What does Valanbio Therapeutics do?

Valanbio Therapeutics, Inc. is a pharmaceutical company.

When was Valanbio Therapeutics founded?

The earliest incorporation on record for Valanbio Therapeutics, Inc. is in 2015, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences